TPX2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.335600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.049000E-01
Normal-vs-Stage2
2.076200E-01
Normal-vs-Stage3
4.083000E-01
Normal-vs-Stage4
3.317200E-01
Stage1-vs-Stage2
1.855750E-01
Stage1-vs-Stage3
6.784600E-01
Stage1-vs-Stage4
5.074800E-01
Stage2-vs-Stage3
4.294400E-01
Stage2-vs-Stage4
5.588200E-01
Stage3-vs-Stage4
8.107400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.417400E-01
Normal-vs-AfricanAmerican
3.651000E-01
Normal-vs-Asian
5.370400E-02
Caucasian-vs-AfricanAmerican
7.081800E-01
Caucasian-vs-Asian
4.365000E-01
AfricanAmerican-vs-Asian
9.230200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.868420E-01
Normal-vs-Female
2.898200E-01
Male-vs-Female
9.600200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.390000E-01
Normal-vs-Age(41-60Yrs)
2.664000E-01
Normal-vs-Age(61-80Yrs)
1.905790E-01
Normal-vs-Age(81-100Yrs)
2.028600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.362800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.879600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.671400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.092400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.140800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.080200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.987400E-01
Normal-vs-Daily Drinker
2.245800E-01
Normal-vs-Weekly Drinker
3.793600E-01
Normal-vs-Occasional Drinker
1.771400E-01
Normal-vs-Social Drinker
1.910160E-01
Non Drinker-vs-Daily Drinker
9.154200E-01
Non Drinker-vs-Weekly Drinker
4.975600E-01
Non Drinker-vs-Occasional Drinker
4.040200E-01
Non Drinker-vs-Social Drinker
9.078400E-01
Daily Drinker-vs-Weekly Drinker
5.322000E-01
Daily Drinker-vs-Occasional Drinker
4.579000E-01
Daily Drinker-vs-Social Drinker
9.830800E-01
Weekly Drinker-vs-Occasional Drinker
8.503200E-01
Weekly Drinker-vs-Social Drinker
5.445600E-01
Occasional Drinker-vs-Social Drinker
5.061600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.537800E-01
Normal-vs-Grade 2
6.043400E-01
Normal-vs-Grade 3
6.384200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.614000E-04
Grade 1-vs-Grade 3
1.76040999999572E-05
Grade 1-vs-Grade 4
5.537800E-01
Grade 2-vs-Grade 3
5.046000E-02
Grade 2-vs-Grade 4
6.043400E-01
Grade 3-vs-Grade 4
6.384200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.057200E-01
Normal-vs-NonDiabetic
2.268400E-01
Diabetic-vs-NonDiabetic
2.236200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.638400E-02
Normal-vs-NoPancreatitis
2.718400E-01
Pancreatitis-vs-NoPancreatitis
5.507800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.608360E-01
Normal-vs-N1
2.380400E-01
N0-vs-N1
3.767400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.957600E-02
Normal-vs-TP53-NonMutant
2.781000E-01
TP53-Mutant-vs-TP53-NonMutant
9.36289999975415E-08
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
